不孕症身心程序对幸福感和辅助生殖结局的临床有效性:一项寻找有效成分的随机对照试验
这项单中心随机对照试验在不孕症身心程序(MBPI)与部分匹配的支持组之间进行比较,发现两组在幸福感各领域均有改善,但MBPI仅在特质焦虑上显示出显著更强的改善(DD=-3.60,调整P=0.042),其他心理健康和辅助生殖结局无显著组间差异。
要点
- 两组在所有心理领域均有显著改善(调整P<0.001),但治疗相关生活质量除外。
- MBPI组特质焦虑改善显著优于支持组(DD=-3.60,调整P=0.042),其他心理指标无显著差异。
- 辅助生殖妊娠、自然妊娠或活产均无显著组间效应。
核心结论
- MBPI的认知行为和结构化压力管理元素使特质焦虑改善显著强于支持组,但其他心理健康和辅助生殖结局无显著差异。
研究设计与样本
- 前后设计、单中心、随机对照试验,于2019年12月至2022年10月进行,样本量n=168,随机分配至MBPI组(n=84)和生育支持(FS)对照组(n=84)。
- 干预为10周、每周135分钟的小组干预,FS组形式相同但内容限制较少且无假定有效因素。
- 分析心理结局人数为MBPI组n=74、FS组n=68,30个月随访时妊娠结局人数为MBPI组n=54、FS组n=56。
主要发现
- 两组在所有心理领域均显著改善(调整P<0.001),但治疗相关生活质量除外。
- 线性混合模型回归分析显示MBPI组在生育相关生活质量(DD=4.11 [0.42, 7.80],d=0.32,调整P=0.124)、治疗相关生活质量(DD=-3.08 [-7.72, 1.55],d=-0.20,调整P=0.582)、不孕特异性压力(DD=-2.54 [-4.68, 0.41],d=-0.36,调整P=0.105)、抑郁(DD=-1.16 [3.61, 1.29],d=-0.13,调整P=0.708)和一般压力(DD=-0.62 [-1.91, 0.68],d=-0.13,调整P=0.708)的改善未显著大于FS组。
- MBPI组在特质焦虑上显示出显著更大的改善(DD=-3.60 [-6.16, -1.04],d=-0.32,调整P=0.042)。
- 逻辑回归显示辅助生殖妊娠、自然妊娠或活产均无显著组间效应。
临床怎么用
- 作者认为MBPI不仅适用于受控条件,也适用于常规辅助生殖实践,可在阶梯式护理框架内作为成本效益好、低强度的心理干预引入。
- 作者指出需要更多研究进一步确定其有效成分。
局限性
- 随访仅涵盖辅助生殖相关医学结局,未涵盖心理变量,且两组率不相等。
- 除年龄、病因和不孕持续时间外的生物学因素可能混杂了研究结果。
- 失访率在5%至10%之间,可能导致一些偏倚。
- 需要更多研究进一步确定其有效成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does the Mind/Body Program for Infertility (MBPI) perform better, due to certain distinctive elements, than a partly matched support group in improving the wellbeing and medically assisted reproduction (MAR) outcomes of women with elevated distress levels in a clinical setting? SUMMARY ANSWER: While robust enhancements occurred in the wellbeing overall, the cognitive behavioural and formalized stress management elements of the MBPI allowed a significantly stronger improvement in trait anxiety, but not in other mental health and MAR outcomes, compared with a support group. WHAT IS KNOWN ALREADY: Mind-body psychological programmes adjacent to MAR have been found to improve women's mental states and possibly increase chances of pregnancy. However, not enough is known about the programme's effectiveness among patients with elevated distress levels in routine clinical settings, nor is it clear which of its particular ingredients are specifically effective. STUDY DESIGN, SIZE, DURATION: A pre-post design, single-centre, randomized controlled trial was performed between December 2019 and October 2022 (start and end of recruitment, respectively). The sample size (n = 168) was calculated to detect superiority of the MBPI in improving fertility-related quality of life. Randomization was computer-based, with random numbers concealing identities of patients until after allocation. PARTICIPANTS/MATERIALS, SETTING, METHODS: The trial was conducted at a large university teaching hospital. A total of 168 patients were randomly assigned to the mind-body (MBPI) group (n = 84) and the fertility support (FS) control group (n = 84). Patients received a 10-week, 135-min/week group intervention, with the FS group following the same format as the MBPI group, but with a less restricted and systematic content, and without the presumed effective factors. The number of patients analysed was n = 74 (MBPI) and n = 68 (FS) for post-intervention psychological outcomes, and n = 54 (MBPI) and n = 56 (FS) for pregnancy outcomes at a 30-month follow-up. MAIN RESULTS AND THE ROLE OF CHANCE: Significant improvements occurred in both groups in all psychological domains (adjusted P < 0.001), except for treatment-related quality of life. Linear mixed-model regression analysis did not reveal significantly greater pre-post improvements in the MBPI group than in the FS group in fertility-related quality of life (difference in differences (DD) = 4.11 [0.42, 7.80], d = 0.32, adjusted P = 0.124), treatment-related quality of life (DD = -3.08 [-7.72, 1.55], d = -0.20, adjusted P = 0.582), infertility-specific stress (DD = -2.54 [-4.68, 0.41], d = -0.36, adjusted P = 0.105), depression (DD = -1.16 [3.61, 1.29], d = -0.13, adjusted P = 0.708), and general stress (DD = -0.62 [-1.91, 0.68], d = -0.13, adjusted P = 0.708), but it did show a significantly larger improvement in trait anxiety (DD = -3.60 [-6.16, -1.04], d = -0.32, adjusted P = 0.042). Logistic regression showed no group effect on MAR pregnancies, spontaneous pregnancies, or live births. LIMITATIONS, REASONS FOR CAUTION: The follow-up only covered MAR-related medical outcomes and no psychological variables, and their rates were not equal in the two groups. Biological factors other than age, aetiology, and duration of infertility may have confounded the study results. Loss to follow-up was between 5% and 10%, which may have led to some bias. WIDER IMPLICATIONS OF THE FINDINGS: The psychologically and medically heterogeneous sample, the normal clinical setting and the low attrition rate all raise the external validity and generalizability of our study. The MBPI works not only in controlled conditions, but also in routine MAR practice, where it can be introduced as a cost-effective, low-intensity psychological intervention, within the framework of stepped care. More studies are needed to further identify its active ingredients. STUDY FUNDING/COMPETING INTEREST(S): The authors received no financial support for the research, authorship, and/or publication of this article. The authors have no conflict of interest to disclose. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT04151485. TRIAL REGISTRATION DATE: 5 November 2019. DATE OF FIRST PATIENT’S ENROLMENT: 15 December 2019.
引用
- Szigeti F J, Kazinczi C, Szabó G, et al. The clinical effectiveness of the Mind/Body Program for Infertility on wellbeing and assisted reproduction outcomes: a randomized controlled trial in search for active ingredients. Hum Reprod. 2024. PMID: 38852061. doi:10.1093/humrep/deae119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。